267 related articles for article (PubMed ID: 34931905)
1. Challenges and Opportunities for Nucleic Acid Therapeutics.
Corey DR; Damha MJ; Manoharan M
Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
[TBL] [Abstract][Full Text] [Related]
2. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
Gait MJ; Agrawal S
Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
[TBL] [Abstract][Full Text] [Related]
3. Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases.
Holm A; Hansen SN; Klitgaard H; Kauppinen S
RNA Biol; 2022; 19(1):594-608. PubMed ID: 35482908
[TBL] [Abstract][Full Text] [Related]
4. [Recent progress and prospect in oligonucleotide therapeutics].
Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
[TBL] [Abstract][Full Text] [Related]
5. The infinite possibilities of RNA therapeutics.
Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
[TBL] [Abstract][Full Text] [Related]
6. RNA therapeutics for metabolic disorders.
Vu TD; Lin SC; Wu CC; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():181-196. PubMed ID: 38359998
[TBL] [Abstract][Full Text] [Related]
7. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
Vetter VC; Wagner E
J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
[TBL] [Abstract][Full Text] [Related]
8. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
9. RNA therapeutics: updates and future potential.
Zhang C; Zhang B
Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies.
Taniguchi H; Suzuki Y; Imai K; Adachi Y
Cancer Sci; 2022 Sep; 113(9):2952-2961. PubMed ID: 35701833
[TBL] [Abstract][Full Text] [Related]
11. Types of RNA therapeutics.
Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
[TBL] [Abstract][Full Text] [Related]
12. Progress on RNA-based therapeutics for genetic diseases.
Luo T; Huo C; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects.
Vaillant A
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146858
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid delivery for therapeutic applications.
Gupta A; Andresen JL; Manan RS; Langer R
Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs.
Gagnon KT; Corey DR
Nucleic Acid Ther; 2019 Jun; 29(3):116-122. PubMed ID: 30907681
[TBL] [Abstract][Full Text] [Related]
16. Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment.
Yamakawa K; Nakano-Narusawa Y; Hashimoto N; Yokohira M; Matsuda Y
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470511
[TBL] [Abstract][Full Text] [Related]
17. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
18. A status update of modified oligonucleotides for chemotherapeutics applications.
Sanghvi YS
Curr Protoc Nucleic Acid Chem; 2011 Sep; Chapter 4():Unit 4.1.1-22. PubMed ID: 21901670
[TBL] [Abstract][Full Text] [Related]
19. RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases.
Germain ND; Chung WK; Sarmiere PD
Mol Aspects Med; 2023 Jun; 91():101148. PubMed ID: 36257857
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic oligonucleotides.
Goodchild J
Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
